Enanta Pharmaceuticals, Inc. (ENTA) earnings
ENTA earnings moved a median of +1.75% by the close. Quarterly and annual ENTA reports and results, each read against the price at its own news timestamp. Back to the ENTA overview →
12 measured ENTA earnings events.
Where these ENTA earnings landedvs 12 measured ENTA earnings reactions
| Middle 50% of ENTA earnings reactions | -0.21% to +4.54% |
|---|---|
| Median reaction (to close) | +1.75% |
| Measured reactions | 12 |
Point-in-time · zero look-ahead
Half of the 12 ENTA earnings events with a measured close landed between -0.21% and +4.54%; 75% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q ENANTA PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | -0.56% | +0.15% | |
| Form 10-Q ENANTA PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | +0.94% | -2.37% | |
| Form 10-Q ENANTA PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-Q | +0.14% | -1.35% | |
| Form 10-K ENANTA PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-K | +0.00% | -1.30% | |
| Form 10-Q ENANTA PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | +0.73% | +3.34% | |
| Form 10-Q ENANTA PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | +1.35% | +3.67% | |
| Form 10-Q ENANTA PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-Q | +8.28% | +21.75% | |
| Form 10-K ENANTA PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-K | +1.41% | +3.76% | |
| Form 10-Q ENANTA PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | -3.25% | +6.89% | |
| Form 10-Q ENANTA PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | -0.54% | +0.15% | |
| Form 10-Q ENANTA PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-Q | +0.00% | +0.16% | |
| Form 10-K ENANTA PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-K | +0.00% | +11.06% |
Keep exploring
More ENTA: analyst actions → · SEC filings → · ENTA overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Haemonetics Corporation (HAE) | 261 | -0.07% | 44% |
| Avanos Medical, Inc. (AVNS) | 259 | 0.00% | 45% |
| FORTY SEVEN (FTSV) | 257 | +0.01% | 51% |
| SELLAS Life Sciences Group, Inc. (SLS) | 257 | -0.63% | 42% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.